For treatment of: nootropic nervous system, brain.Ceraxon nootropics
- For the treatment of internal organs: nervous system, brain
- Appointment: cognitive impairment, ischemic stroke, traumatic brain injury, prevention and treatment of ischemic neurological disorders
- Indications for use:
— acute period of ischemic stroke (as part of complex therapy);
— recovery period of ischemic and hemorrhagic strokes;
— traumatic brain injury, acute (as part of complex therapy) and recovery period;
— cognitive and behavioral disorders in degenerative and vascular diseases of the brain.
— pronounced vagotonia (predominance of the tone of the parasympathetic part of the autonomic nervous system);
— children and adolescents under 18 years of age (due to lack of sufficient clinical data);
— hypersensitivity to the components of the drug.
Active substance: citicoline – 1000 mg
Excipients: hydrochloric acid 1 M or sodium hydroxide 1 M – up to pH 6.5-7.1, water d/I – up to 4 ml
- Manufacturer: Takeda